- Home
- GNTY vs DNTH Comparison
GNTY vs DNTH Comparison
Compare GNTY & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTY
- DNTH
- Stock Information
- Founded
- GNTY 1913
- DNTH 2015
- Country
- GNTY United States
- DNTH United States
- Employees
- GNTY N/A
- DNTH N/A
- Industry
- GNTY Major Banks
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- GNTY Finance
- DNTH Health Care
- Exchange
- GNTY Nasdaq
- DNTH Nasdaq
- Market Cap
- GNTY 520.5M
- DNTH 606.2M
- IPO Year
- GNTY 2017
- DNTH N/A
- Fundamental
- Price
- GNTY $42.64
- DNTH $20.59
- Analyst Decision
- GNTY Buy
- DNTH Strong Buy
- Analyst Count
- GNTY 2
- DNTH 8
- Target Price
- GNTY $44.50
- DNTH $53.00
- AVG Volume (30 Days)
- GNTY 51.7K
- DNTH 371.4K
- Earning Date
- GNTY 07-21-2025
- DNTH 08-11-2025
- Dividend Yield
- GNTY 2.29%
- DNTH N/A
- EPS Growth
- GNTY 37.68
- DNTH N/A
- EPS
- GNTY 3.13
- DNTH N/A
- Revenue
- GNTY $127,325,000.00
- DNTH $6,524,000.00
- Revenue This Year
- GNTY $10.99
- DNTH N/A
- Revenue Next Year
- GNTY $4.83
- DNTH N/A
- P/E Ratio
- GNTY $13.61
- DNTH N/A
- Revenue Growth
- GNTY 10.12
- DNTH 102.36
- 52 Week Low
- GNTY $29.65
- DNTH $13.37
- 52 Week High
- GNTY $47.20
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- GNTY 40.83
- DNTH 52.74
- Support Level
- GNTY $44.02
- DNTH $21.27
- Resistance Level
- GNTY $46.55
- DNTH $23.21
- Average True Range (ATR)
- GNTY 1.18
- DNTH 1.25
- MACD
- GNTY -0.43
- DNTH -0.07
- Stochastic Oscillator
- GNTY 13.01
- DNTH 39.77
About GNTY Guaranty Bancshares Inc.
Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.